Co-founder of Kinimmune and Director of Business Development at Bond Biosciences, Danny is a VC Fellow with BioGenerator Ventures.
At BioGenerator, Danny brings a specialty in Therapeutics to assist the ventures team in conducting technical and commercial diligence on investment opportunities in biotechnology.
Danny holds a PhD in Bioengineering from the University of Kansas where he was funded by the PhRMA foundation, NIH/NINDS, and Madison and Lila Self Graduate Fellowship. Danny’s research was focused on developing translational immunotherapies and was selected for the Argersinger Prize in 2020.
